The Healthcare Infection Society (HIS) is drafting the scope for our new guideline on the topic of infection prevention and control of Aspergillus.

The incidence of invasive fungal infections has increased in the last few years. These infections are a major cause of morbidity and high mortality in susceptible populations worldwide. Aspergillosis is a particular concern for immunocompromised patients who, when affected, often develop pulmonary infections that may rapidly progress into invasive and/or disseminated disease. Aspergillus spores are ubiquitous in a wide range of environments including soil and organic matter and can be easily dispersed via air. Their widespread presence in healthcare settings and the threat they pose to health is well described in literature.

The HIS guideline will be an international guideline developed according to our NICE accredited methodology. We are seeking stakeholder views on the topic areas and the scope that guideline should cover. 

Please submit your comments using the feedback form below. Please be aware that we are not able to consider your comments if you do not complete and sign the Conflict of Interest declaration attached at the end of the form.

Please send your responses to consultations@his.org.uk by 5pm 11 July 2024. 

Please find below the draft scope under consultation and the feedback form to download.